LeonaBio warrants become exercisable at $6.35 a share, could raise about $146.2 million

PUBT · 3d ago
LeonaBio warrants become exercisable at $6.35 a share, could raise about $146.2 million
  • LeonaBio triggered exercisability of 23,031,494 Series A Common Warrants by announcing enrollment of the 500th ELAINE-3 patient.
  • Warrants carry a USD 6.35 per-share cash exercise price, with cashless net exercise allowed if no resale registration statement is available.
  • Initial exercise date is the earlier of the specified milestone date or Oct. 31, 2026; termination occurs 30 days later.
  • Full exercise would deliver about USD 146.2 million in gross proceeds.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LeonaBio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-368288), on August 26, 2026, and is solely responsible for the information contained therein.